Delivery Order SPE2DR25D1002-SPE2DR26FGK7A
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,064.29 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. This firm fixed-price, non-set-aside delivery order was awarded on October 21, 2025, with an ultimate completion date of October 22, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,536.83 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, on November 18, 2025. This non-set-aside, firm fixed price delivery order is scheduled for completion by November 19, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a standard transactional purchase under the company's broader federal contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,378.41 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the performing location and is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $14,351.01 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in a 60-dose inhaler configuration. This competitively awarded, firm fixed-price delivery order was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $13,755.65 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol. The order, with an ultimate completion date of June 2, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.80 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone propionate, umeclidinium, and vilanterol. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,949.47 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, classified as a child contract with no set-aside designation. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $12,522.24 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued to the vendor's corporate office located in Conshohocken, Pennsylvania. The contract utilizes AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $8,521.98 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of December 8, 2025. This is a firm fixed-price, non-set-aside competitive award issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the products will be performed. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGK7ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.53 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol. The award, issued December 4, 2025, with an ultimate completion date of December 5, 2025, was competitively awarded without set-aside designation and carries firm fixed pricing. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The SPE2DX prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. This delivery order represents a routine pharmaceutical fulfillment under the broader contract vehicle, supporting DLA's ongoing medical supply chain operations for defense health requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/3/25 |